Disparity in Quality of Infectious Disease vs Addiction Care Among Patients With Injection Drug Use-Associated Staphylococcus aureus Bacteremia

David Phillip Serota; Emily D Niehaus; Marcos C Schechter; Jesse T Jacob; Jeb Jones; Susan M Ray; Colleen F Kelley; Russell R Kempker

doi:10.1093/ofid/ofz289

Disparity in Quality of Infectious Disease vs Addiction Care Among Patients With Injection Drug Use-Associated Staphylococcus aureus Bacteremia

Open Forum Infect Dis. 2019 Jun 18;6(7):ofz289. doi: 10.1093/ofid/ofz289. eCollection 2019 Jul.

Authors

David Phillip Serota¹, Emily D Niehaus², Marcos C Schechter¹, Jesse T Jacob¹, Jeb Jones³, Susan M Ray^{1

4}, Colleen F Kelley¹, Russell R Kempker¹

Affiliations

¹ Division of Infectious Diseases, Department of Medicine.
² Department of Medical Education, Emory University School of Medicine, Atlanta, Georgia.
³ Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia.
⁴ Grady Health System, Atlanta, Georgia.

Abstract

Evidence-based interventions for Staphylococcus aureus bacteremia (SAB) are well known, but it is unclear how they are implemented among patients with injection drug use-associated (IDU) SAB. Of 46 patients with IDU-SAB identified, all received high-quality SAB management; however, few received appropriate recognition or treatment of their underlying substance use disorder.

Keywords: Staphylococcus aureus; bacteremia; endocarditis; injection drug use; substance use disorder.

Abstract

Grants and funding